Unveiling the homecare medicine landscape
Clinical homecare has recently garnered negative attention and has become the subject of a House of Lords inquiry. Triggered by whistleblowers from patient groups and clinicians, the inquiry has put a spotlight on longstanding deficiencies in homecare medicine services, some of which have led to patient harm. The resulting report, titled ‘Homecare Medicines Services – An Opportunity Lost,’ appropriately captures the inquiry’s observation that when homecare functions well, patients appreciate it, and there exists significant potential to alleviate pressure on the NHS by delivering care to people’s homes.
However, the report underscored significant shortcomings, including delays in initiating patient treatment and instances of missed doses due to delivery issues. Surprisingly, the inquiry acknowledged its inability to ascertain the extent of harm caused by delays or missed deliveries, emphasising a lack of knowledge on the government’s part regarding the number of affected individuals. This deficiency in information and comprehension constitutes a genuine oversight failure.
In a series of concise articles, we will delve into how ai365 addresses this gap by offering comprehensive insights into homecare services. It also delivers governance excellence to pharmaceutical companies and NHS hospitals currently utilising it. ai365, a secure and sophisticated online analytical tool and data repository, facilitates holistic and robust management and governance of patient support and homecare medicines services.